OGP-derived peptides

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameOGP-derived peptides
Drug Alias NameN/A
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionUpdating
TargetsNot applicable
Therapy Area/IndicationsPrimary MyelofibrosisAnemiaOsteoarthritis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAbiogen Pharma Spa
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAbiogen Pharma Spa
Active IndicationsN/A
Inactive IndicationsPrimary MyelofibrosisAnemiaOsteoarthritis

Other Information

ATC CodeN/A
Related LinksN/A